Efficacy Study of FANG(30) for Active Rheumatoid Arthritis in Adult Patients

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2008
This is a Clinical Pilot Phase II interventional, double blind, randomized and placebo controlled study to document the efficacy, tolerability and safety of FANG(30) in 60 adult patients affected with active Rheumatoid Arthritis. Also, to evaluate the effect of an andrographolide natural formula, identified as FANG(30) or \"the study product\", on the immunological functions that influence chronic inflammatory process in these patients, who could benefit with this treatment.
Epistemonikos ID: 1a5da62353666d68f7dd0209bb33b94cb0e7125d
First added on: Nov 24, 2021